YOLFTbeta
60

Dashenlin Pharm Grp Co Ltd

603233 · SHG · Healthcare / Pharmaceutical Retailers

20.45CNY+0.18 (+0.89%)

Price History

Full chart

Market Stats

Previous Close20.27
Open20.27
Day Range20.00 – 20.72
52-Week Range14.39 – 21.78
Volume11.88M
Market Cap20.73B
P/E (TTM)15.29
Forward P/E0.00
EPS1.19
Dividend Yield4.56%
Beta0.41
50-Day Avg18.22
200-Day Avg18.17

About

DaShenLin Pharmaceutical Group Co., Ltd. engages in the manufacture, distribution, and retail of pharmaceutical products in China. It offers Chinese and Western patent medicines, ginseng and tonic herbs, Chinese herbal medicine slices, health products, medical devices, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China.

Company Details

  • SectorHealthcare
  • IndustryPharmaceutical Retailers
  • CEOMr. Guoqiang Ke
  • Employees41.14K
  • HeadquartersNo. 410-1, Longxi Avenue, Guangzhou, China, 51000, China
  • Websitehttps://www.dslyy.com

Leadership

  • Mr. Guoqiang KeGM & Director · b. 1982
  • Mr. Guangzhi PengFinancial Director & Secretary to the Board · b. 1982
  • Ms. Qun Fei TanDeputy GM & Director · b. 1967
  • Mr. Hong ChenDeputy General Manager · b. 1977
  • Ms. Xin JiangDeputy General Manager · b. 1970
  • Mr. Changcheng ChenDeputy General Manager · b. 1984
  • Mr. Tuo Ji KeDeputy GM & Director · b. 1995

Financials

Income Statement

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue3.25B3.71B4.55B5.27B6.27B7.42B8.86B11.14B14.58B16.76B21.25B24.53B26.50B27.50B
Growth (%)-+13.96%+22.62%+15.85%+19.15%+18.29%+19.38%+25.76%+30.89%+14.92%+26.78%+15.45%+8.01%+3.80%
Cost of Revenue2.06B2.26B2.71B3.11B3.75B4.44B5.18B6.75B8.99B10.39B13.23B15.80B17.42B18.06B
Gross Profit1.19B1.44B1.83B2.16B2.52B2.98B3.68B4.39B5.59B6.37B8.02B8.74B9.07B9.44B
Gross Margin36.56%38.90%40.28%41.03%40.17%40.14%41.57%39.39%38.33%38.03%37.76%35.61%34.25%34.32%
Operating Expense925.34M1.13B1.42B1.61B1.94B2.35B2.96B3.47B4.14B5.33B6.60B7.10B7.72B7.34B
Operating Income263.77M315.61M411.36M547.87M578.35M633.32M718.30M918.26M1.45B1.04B1.42B1.63B1.35B2.10B
Operating Margin8.11%8.51%9.05%10.40%9.22%8.53%8.11%8.24%9.93%6.21%6.69%6.65%5.11%7.62%
EBITDA263.77M342.76M541.70M680.19M661.43M727.81M831.28M1.06B1.53B1.31B1.81B3.24B3.13B3.47B
EBITDA Margin8.11%9.25%11.92%12.92%10.54%9.81%9.38%9.50%10.51%7.79%8.51%13.22%11.82%12.63%
Net Income149.18M197.38M265.50M395.43M430.19M474.96M531.63M702.66M1.06B791.23M1.04B1.17B914.75M1.24B
Net Income Margin4.59%5.33%5.84%7.51%6.86%6.40%6.00%6.31%7.28%4.72%4.87%4.76%3.45%4.49%
R&D----168.00K-609.00K434.49K4.70M44.61M74.38M80.93M51.68M41.27M
R&D as % of Total Revenue----0.00%-0.01%0.00%0.03%0.27%0.35%0.33%0.20%0.15%
Interest Expense010.04M41.13M35.83M32.92M34.29M47.58M55.33M38.48M238.48M270.69M275.34M282.33M77.34M
Interest Expense % of Total Revenue0.00%0.27%0.90%0.68%0.52%0.46%0.54%0.50%0.26%1.42%1.27%1.12%1.07%0.28%

Balance Sheet

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets996.51M1.68B2.37B2.66B3.58B5.82B6.54B8.67B12.33B17.34B20.84B24.12B26.44B26.49B
Total Liabilities615.39M1.09B1.79B1.64B2.24B3.02B3.45B4.34B6.76B11.40B13.98B16.19B18.30B17.83B
Total Equity328.26M525.64M500.14M1.02B1.32B2.75B3.04B4.24B5.38B5.48B6.21B6.82B6.90B7.37B
Cash190.07M275.75M603.33M526.69M668.45M1.08B1.33B1.72B3.75B2.79B4.49B4.42B6.22B6.51B
Total Debt126.20M290.00M510.00M260.34M409.18M515.18M352.83M329.29M1.40B5.28B5.93B5.44B6.32B-
Net Debt-63.88M14.25M-93.33M-266.35M-259.27M-566.32M-976.18M-1.39B-2.35B2.48B1.44B1.02B103.88M-

Cash Flow

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow289.31M288.22M448.58M468.59M495.60M640.39M873.64M1.71B1.95B1.55B3.76B3.17B3.11B5.35B
Investing Cash Flow-57.50M-361.25M-291.83M-205.47M-425.41M-1.43B-317.40M-1.66B-1.07B-967.70M-1.29B-1.99B-1.94B-
Financing Cash Flow-159.14M100.63M-127.31M-255.17M11.72M1.06B-436.66M420.18M1.21B-1.61B-933.57M-1.97B-931.93M-
Capital Expenditure59.85M363.99M261.82M247.84M307.35M668.53M554.39M501.41M792.32M1.29B1.03B1.80B1.48B484.84M
Free Cash Flow229.46M-75.77M186.76M220.75M188.25M-28.14M319.25M1.21B1.16B260.05M2.72B1.38B1.63B4.87B
Dividends Paid82.32M47.25M321.50M21.32M160.27M20.53M262.74M240.01M328.17M526.90M395.46M569.45M753.21M782.10M
FCF to OCF79.31%-26.29%41.63%47.11%37.98%-4.39%36.54%70.64%59.45%16.72%72.45%43.39%52.49%90.94%
Dividend Paid to FCF35.88%-62.36%172.14%9.66%85.14%-72.94%82.30%19.90%28.25%202.61%14.53%41.35%46.20%16.07%

Earnings

Report DateOct 26, 2017Dec 31, 2017Apr 27, 2018Aug 28, 2018Oct 29, 2018Apr 29, 2019Aug 27, 2019Oct 30, 2019Apr 27, 2020Aug 27, 2020Oct 30, 2020Apr 19, 2021Aug 29, 2021Oct 27, 2021Dec 31, 2021Apr 27, 2022Aug 29, 2022Oct 27, 2022Dec 31, 2022Apr 27, 2023Aug 29, 2023Oct 30, 2023Feb 8, 2024Apr 28, 2024Aug 30, 2024Oct 30, 2024Apr 25, 2025Aug 28, 2025Oct 29, 2025Dec 31, 2025Apr 23, 2026Aug 24, 2026
EPS Estimate-----0.140.260.290.21-0.190.160.380.280.200.190.350.350.150.390.340.220.100.110.360.240.310.240.180.040.460.34
EPS Actual0.130.090.160.160.140.160.260.230.240.330.240.160.320.16-0.04-0.050.340.190.100.440.350.220.22-0.020.230.180.400.300.250.130.450.36
Surprise-----14.29%0.00%-20.69%14.29%-26.32%0.00%-15.79%-42.86%-120.00%-126.32%-2.86%-45.71%-33.33%12.82%2.94%0.00%120.00%-118.18%-36.11%-25.00%29.03%25.00%38.89%218.25%-2.17%5.88%
TimingAfter-hours-Pre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-market-Pre-marketPre-marketAfter-hours-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hours-After-hoursPre-market

Key Statistics & Ratios

Market Cap20.73B
Enterprise Value19.56B
Trailing P/E15.29
Forward P/E0.00
Price / Sales0.74
Price / Book2.65
EPS1.19
Book Value6.79
Revenue (TTM)27.97B
Gross Profit (TTM)9.67B
EBITDA2.49B
Profit Margin4.88%
Operating Margin9.40%
Return on Equity17.04%
Return on Assets5.43%
Shares Outstanding1.14B
Shares Float407.73M
Beta0.41
Dividend Yield4.56%
Dividend Rate0.83
Payout Ratio69.75%

Dividends

20231×
0.60Jun 9, 2023
20221×
0.42Jun 13, 2022
20211×
0.56Jun 10, 2021
20201×
0.35Jun 17, 2020
20191×
0.29May 30, 2019
20181×
0.22Jun 19, 2018

Stock Splits

  • Jun 9, 20236:5
  • Jun 13, 20226:5
  • Jun 10, 20216:5
  • Jun 17, 20206:5
  • May 30, 201913:10